Supporting play exploration and early developmental intervention versus usual care to enhance development outcomes during the transition from the neonatal intensive care unit to home: a pilot randomized controlled trial

Dusing, Stacey C.; Tripathi, Tanya; Marcinowski, Emily C.; Thacker, Leroy R.; Brown, Lisa F.; Hendricks-Muñoz, Karen D.

doi:10.1186/s12887-018-1011-4

Table 3 Description of subjects

From: Supporting play exploration and early developmental intervention versus usual care to enhance development outcomes during the transition from the neonatal intensive care unit to home: a pilot randomized controlled trial

	Total n = 14	Control n = 7	SPEEDI n = 7	p-value^e
Maternal Age^b	29.50 (27.00, 31.00)	31.00 (29.00, 42.00)	27.00 (23.00, 31.00)	0.05^d
Maternal Education^a				0.14^c
HS or Less	46% (6/13)	33% (2/6)	57% (4/7)
Some College	23% (3/13)	50% (3/6)	0% (0/7)
College or More	31% (4/13)	17% (1/6)	43% (3/7)
Household Income^a
< $24,000 (poverty)	50% (7/14)	57% (4/7)	43% (3/7)	1.00^c
$24,001 - $ 36,000	50% (7/14)	43% (3/7)	57% (4/7)
> $36,001 (1.5 time poverty)	0% (0/14)	0% (0/7)	0% (0/7)
Gender Male^a	57% (8/14)	43% (3/7)	71% (5/7)	0.59^c
Birth Weight (g)^b	795.00 (615.00, 1190.00)	840.00 (700.00, 320.00)	680.00 (580.00, 1190.00)	0.48^d
Gestational Age (wks)^b	25.50 (25.00, 27.00)	26.00 (25.00, 28.00)	25.00 (24.00, 27.00)	0.44^d
Race^a
Caucasian	14% (2/14)	14% (1/7)	14% (1/7)
African American	72% (10/14)	72% (5/7)	72% (5/7)
Biracial	7% (1/14)	0% (0/7)	14% (1/7)
Other	7% (1/14)	14% (1/7)	0% (0/7)
Ethnicity^a
Hispanic	7% (1/14)	14% (1/7)	0% (0/7)
Non-Hispanic	93% (13/14)	86% (6/7)	100% (7/7)
IVH (Any grade)^a	36% (5/14)	14% (1/7)	57% (4/7)	0.27^b
IVH Grade 3 or 4^a	14% (2/14)	14% (1/7)	14% (1/7)	1.00^b
HIE^a	7% (1/14)	14% (1/7)	0% (0/7)	1.00^c
PVL^a	14% (2/14)	0% (0/7)	29% (2/7)	0.46^b
Days in NICU^b	116.50 (93.00, 125.00)	93.00 (65.00, 107.00)	125.00 (116.00, 126.00)	0.14^d
NMI Rating^b	5.00 (4.00, 5.00)	5.00 (4.00, 5.00)	5.00 (5.00, 5.00)	0.06^d
Adjusted Age^b
Baseline (weeks of gestation)	38 (35, 39)	35 (35, 39)	39 (36, 40)	0.05^d
End Phase 1 (weeks of gestation)	40 (38, 42)	38 (38, 41)	42 (40, 43)	0.05^d
End phase 2 (weeks of adjusted age or beyond 40 weeks of gestational age)	13.5 (11.0, 15.0)	13.0 (11.0, 14.0)	15.0 (13.0, 15.0)	0.28^d
Follow-up 1 (1 month after intervention)	18.0 (16.0, 19.0)	16.0 (15.0, 18.0)	19.0 (18.0, 20.0)	0.09^d

Notes: ^aPercent (n/total)
^bMedian (IQR)
^cFisher’s Exact Test
^dMann-Whitney U Test (Wilcoxon Rank-sum test)
^eBetween Group Differences Unadjusted for multiple comparisons

Back to article page

ISSN: 1471-2431

Contact us

Submission enquiries: bmcpediatrics@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Pediatrics

Contact us